HYUNDAI BIOSCIENCE (048410) Financial Statements

OverviewFinancialsChecksFilings

In fiscal year 2025, HYUNDAI BIOSCIENCE (048410) reported revenue of 3.5 billion KRW.

Income Statement

YearRevenueOp ProfitNet IncomeSource
20253.5 billion KRW-18.2 billion KRW-22.1 billion KRW[source]
202415.1 billion KRW791 million KRW-6.9 billion KRW[source]
20239.5 billion KRW-9.8 billion KRW-14.5 billion KRW[source]
20227.9 billion KRW-26.4 billion KRW-15.8 billion KRW[source]
20219.2 billion KRW-9.8 billion KRW-20.1 billion KRW[source]

Balance Sheet

YearTotal AssetsTotal LiabilitiesTotal EquitySource
2025133.0 billion KRW20.0 billion KRW113.0 billion KRW[source]
202473.5 billion KRW28.3 billion KRW45.2 billion KRW[source]
202352.7 billion KRW7.2 billion KRW45.5 billion KRW[source]
202266.6 billion KRW8.2 billion KRW58.4 billion KRW[source]
202174.9 billion KRW17.1 billion KRW57.8 billion KRW[source]
Financials & Filings: DART (traceable by receipt number) · Prices: Financial Services Commission · Data Sources · Last checked: 2026-08-29 · About · Delisting market cap threshold: KOSPI 5B KRW / KOSDAQ 4B KRW (per listing rules) · This page provides factual information, not investment advice